Phase 2 multicohort study of CC-90011, a LSD1 inhibitor, in combination with nivolumab in patients with advanced lung cancer Meeting Abstract
| Authors: | Rudin, C. M.; Navarro, A.; Carcereny, E.; Villaruz, L. C.; Lo Russo, G.; Ricordel, C.; Bearz, A.; Li, J.; Elias, I.; Bhingare, A.; Morris, E.; Popat, S. |
| Abstract Title: | Phase 2 multicohort study of CC-90011, a LSD1 inhibitor, in combination with nivolumab in patients with advanced lung cancer |
| Meeting Title: | 2023 World Conference on Lung Cancer (IASLC-WCLC) |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 18 |
| Issue: | 11 Suppl. |
| Meeting Dates: | 2023 Sep 9-11 |
| Meeting Location: | Singapore |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2023-11-01 |
| Start Page: | S169 |
| Language: | English |
| DOI: | 10.1016/j.jtho.2023.09.251 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting Abstract: MA18.10 -- Source: Cinahl |
